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ABSTRACT 
Endometrial cells isolated from uteri of ovariectomized rats were treated in vitro 
with  1  x  10 4  M  estradiol-17fl  (Ezfl) to  analyze  early changes  in  membrane 
properties  during  hormone-induced growth.  After  30-min  exposure  to  E2fl at 
22~  cells exhibited an enhanced capacity to bind erythrocytes (hemadsorption) 
in  the  presence  of concanavalin  A  (Con  A)  to  237%  of the  level  in  paired 
controls. Fluorescence microscopy revealed that -25%  of cells exposed to F_~fl, 
but not estradiol-17 ot (E~ a), showed a redistribution into polar clusters of Con A- 
binding sites that were dispersed in random patches at the external surfaces of 
control cells.  These hormone-induced membrane  alterations were abolished by 
prior treatment of cells with inhibitors of thiol proteinase activity of the cathepsin 
B1  (CB1) type, such as leupeptin and iodoacetate. Leupeptin at 4.5  ￿  10 -7 M 
also reduced the affinity of [aI-I]E2fl binding to intact cells but did not influence 
specific binding  of the  hormone  to macromolecular components of cytosol. A 
pronounced increase in the availability of endogenous CB1,  but not of alkaline 
phosphatase, succinate, or lactate dehydrogenase, in the extracellular media was 
elicited within 30 min after F_~fl treatment. In cells cultured in chemically defined 
medmm  for  up  to  48  h,  E2fl,  but  not  E2a,  enhanced  cell  proliferation  and 
stimulated  [aH]thymidine incorporation into macromolecular form. These E2fl- 
induced  effects were  abolished  by  prior  treatment  of cells  with  liposome-en- 
trapped  leupeptin  at  a  final  concentration  of 7  ￿  10 -8  M.  The  net  rate  of 
intercellular adhesion among endometrial cells was also enhanced by E2fl. This 
hormonal response was diminished by prior exposure to leupeptin. Fractionation 
of cells by selection for adhesiveness due to E2fl exposure for 30 rain yielded a 
subpopulation  of  rapidly  dividing  cells  which  surpassed  their  less  adhesive 
counterparts in cathepsin secretion and in Con A-mediated hemadsorption. These 
results  indicate  that  leupeptin-sensitive  proteinase  activity  may  contribute  to 
membrane  and  growth modifications elicited by E2fl treatment  in  endometrial 
cells. 
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649 Specific binding of estradiol-17fl  (E2/3)  to  extra- 
nuclear  macromolecules  is  well documented  (cf. 
reference  18).  These  receptor  components  func- 
tion  in  transfer  of  the  hormone  to  the  nuclear 
compartment, where the complex appears to pro- 
mote expression of the phenotypic effects (8,  19, 
23,  25).  Additional  data  indicate  that  limited 
hydrolysis of the  native  receptor  by  a  Ca2%acti  - 
vated proteinase occurs concomitant with the for- 
mation of the mobile estrogen-binding derivative 
which  enters  the  nucleus  (47,  52).  Moreover, 
estrogen-induced translocation of Ca2§ 
cathepsin  Bl-like  (59)  and  of  trypsin-like  (24) 
proteinase  activities to  the  nuclear compartment 
of target cells has also been reported. 
Mild treatment of normal cells with exogenous 
proteinases is known  to lead to alterations in the 
cell surface (cf. references 9 and 33) and a level of 
cell growth (cf. references 9, 10, and 33) that are 
usually  seen  only in  transformed  or tumor  cells. 
Moreover,  changes  in  lectin-mediated  agglutina- 
bility  (42),  Ca  z+  exchange  (40),  and  proteinase 
availability  (43)  at  the  surface  membranes  of 
isolated  endometrial  cells  have  been  detected 
shortly after their exposure  to estrogens in vitro. 
In turn,  enhanced  mitotic activity of endometrial 
cells 24 h  after estrogen treatment  (15) is closely 
correlated with increased thymidine incorporation 
into DNA  (17,  28).  Preliminary findings indicate 
that  enhancement  of  DNA  synthesis  and  the 
precedent membrane alterations in isolated endo- 
metrial  cells after  exposure  to  estrogens  may be 
associated with increased availability of proteinase 
activity in the stimulated cells (45).  Recent iden- 
tification of binding  sites specific for  E2/3  at  the 
plasma  membranes  of cells sensitive  to  the  hor- 
mone  (39,  44)  raises  further  questions  on  the 
nature  of  mechanisms  coupling  ligand-induced 
surface perturbation with processes leading to cell 
proliferation.  Accordingly,  the  present  experi- 
ments were conducted to investigate the contribu- 
tion of endogenous  proteinase  activity to  media- 
tion  of  estradiol  binding  and  responses  to  hor- 
mone in isolated endometrial cells. 
MATERIALS  AND  METHODS 
Isolation of Endometrial Cells 
Uteri were excised from female rats  that  had  been 
ovariectomized at 6 wk of age and maintained for 3 wk 
in  a  low steroid  environment  (56).  Endometrial  cells 
were isolated from the mucosal surfaces of 50-70 uteri 
in  each  experiment  by  procedures  employing 20  mg 
collagenase  (type  I;  Worthington  Biochemical Corp., 
Freehold, N. J.)/100 ml Ringer's solution supplemented 
with  0.1%  (wt/vol)  highly purified  albumin  (Pentex; 
Miles Laboratories,  Inc., Elkhart,  Ind.)  and otherwise 
as described previously (41, 42). The yield of endome- 
trial cells averaged approx.  1  x  10  ~ cells per uterus or 
2.7% of total uterine DNA (see below), a value corre- 
sponding well with previous estimates from experiments 
with uteri of ovariectomized rodents (1, 54). 
At the start of most experimental manipulations, the 
intact  cells  were  suspended  in  Ringer's solution  com- 
posed of 136.9 mM NaCI, 2.7 mM KC1, 0.5 mM CaClz, 
0.5 mM MgC12, 1 mM sodium pyruvate and buffered at 
pH 7.4 with 8.1  mM Na2HPO4 and  1.5  mM KH2PO4. 
Essentially all vessels  used for these preparations were 
polyethylene, polycarbonate, or polypropylene. All ma- 
terials and  instruments  used  in these  procedures  were 
obtained  sterile or  autoclaved,  and  all solutions  were 
filter-sterilized. 
Determination of [ZH]E~fl Binding by Intact 
Cells and Their High-Speed Supernatant 
Fractions 
Levels of estradiol binding in intact cells were deter- 
mined by methods described previously (44).  In brief, 
endometrial cells were suspended in Ringer solution to a 
final concentration of 2  x  107 cells/ml. Incubations of 
30  min duration were begun with the addition of 1  x 
10 -~ M  [2,4,6,7-aH]E~fl  (99  Ci/mmol; New  England 
Nuclear, Boston,  Mass.)  at 22~  in  an atmosphere  of 
100%  02 and with shaking at a rate of 90 oscillations/ 
min.  A  200-fold  excess  of  unlabeled  E~fl  (Schering 
Corp,, Kenilworth, N. J.) was added to paired samples 
for determination of displaceable binding (cf. reference 
62). 
High-speed supernatant  (i.e., cytosol) fractions were 
prepared from freshly isolated endometrial cells at 4~ 
by slight  modification of the method  of Jensen  et al. 
(23). In brief, intact cells were homogenized in 4 vol of 
10 mM Tris-HC1 buffer (pH 7.4) with 1.5 mM disodium 
EDTA. Approximately 15 manual up-and-down strokes 
with a glass-glass homogenizer were sufficient to disrupt 
the endometrial cells as judged by phase-contrast micros- 
copy. The homogenate was diluted with an equal volume 
of buffer  and  filtered  twice  over two  layers  of nylon 
mesh with an average pore size of 35/zm (Nitex; Tobler, 
Ernst, and Traber, Inc., Elmsford, N. Y.). The filtrate 
was centrifuged at  105,000 g for 1 h. The particle-free 
supernate  was  collected  and  incubations  were  begun 
with the addition of I  ￿  10 -9 M [aH]E2fl at 4~  A 200- 
fold  excess  of  unlabeled  E2/3 was  present  in  paired 
samples for determination of displaceable binding. An 
incubation time of 2 h was used in these experiments to 
allow sufficient  time for the binding process to achieve 
equilibrium at  4~  After 2  h,  the  free estradiol was 
removed by the dextran-coated charcoal procedure (26), 
and  aliquots of the  samples  were analyzed  for bound 
[all]E2/3 by liquid scintillation  counting. 
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Incorporation  o  f [~H]Thymidine  into 
Macromolecular Form in Endometrial 
Cell Cultures 
Isolated endometrial cells  were cultivated in  serum- 
free, chemically defined medium (CDM) in a humidified 
atmosphere of 5%  CO2 in air at 37~  CDM consisted 
of Earle's balanced salt  solution enriched with  1 mM 
dextrose, 1 x  10 --s M highly purified crystalline  bovine 
insulin (Eli Lilly and Co., Indianapolis, Ind.), 0.1% (wt/ 
vol) albumin (Pentex), Modified Eagle's Medium amino 
acids  adjusted  to  physiological  concentrations (Grand 
Island Biological  Co., Grand Island, N. Y.), and Gen- 
tamicin (50  /xg/ml; Schering Corp.). After 2-d incuba- 
tion, the CDM was removed and endometrial cells were 
washed with 2 ml of fresh solution. 5 ml of new CDM 
with or without test compounds was then added to each 
dish. Incorporation of [6-aH]thymidine  (NET 355;  10.5 
Ci/mmol; New England Nuclear) into acid-precipitable 
form from cell cultures after 20-h incubation was meas- 
ured as described previously (38). 
In  independent experiments, proliferation of endo- 
metrial cells after 24- or 48-h incubation was determined 
from cell numbers. Cells were suspended in Ca  2+-, Mg  2+- 
free Ringer's solution in the presence of 1.5  M EDTA 
and counted in a bright-line double Neubauer counting 
chamber  using  phase-contrast  optics.  In  25  separate 
experiments, the  cell  numbers over a  range of values 
from 1.5 to 5.0  ￿  106 showed a positive linear correla- 
tion (r  =  0.94) with DNA levels  in paired samples, as 
determined by  the  method of Hill  and  Whatley (20). 
The DNA concentrations in these experiments averaged 
8.4 -+ 0.2/xg/lO  ~ endometrial cells. 
Concanavalin A  Binding and Concanavalin 
A-Mediated Hemadsorption to Isolated 
Endometrial Cells 
Specific binding of 100  /xg concanavalin A  (Con A; 
Calbiochem-Behring Corp., American Hoechst Corp., 
San  Diego,  Calif.)/ml to  endometrial cells  was deter- 
mined with  fluorescein-labeled Con  A  (F.Con  A)  as 
described by Pietras and Szego (42). Assessment of Con 
A-mediated adsorption of homologous erythrocytes to 
isolated endometrial cells (i.e., hemadsorption) was car- 
ried out as previously published (42). 
Dark-Field  Ultraviolet Fluorescence 
Microscopy 
Photomicrographs were obtained with a Leitz Ortho- 
lux microscope, using a xenon light  source, XBO  150. 
The  exciting  filter combination consisted of a  BG  38 
heat-barrier filter, a Leitz 480 nm filter, and a Leitz KP 
490 interference filter;  a K  510  nm filter served as the 
barrier filter.  Distribution of fluorescein label was ana- 
lyzed after thorough washing of preparations (1.5  x  10  ~ 
cells/ml) that had been treated with 100/xg F. Con A/ml 
for 3 min at 22~  as described previously (37,42). 
Analyses of Extracellular Hydrolase 
Activities 
Suspended endometrial cells (approx. 6  ￿  106 cells/2 
ml  Ringer's solution) were  incubated with or without 
additives for selected times in a Dubnoff shaking incu- 
bator  at  22~  The  cells  were  then  sedimented by 
centrifugation at  400 g  for 5  min at  4~  in  a  Sorvall 
RC2-B  centrifuge  (DuPont  Instruments,  Wilmington, 
Del.). Particle-free supematant fractions of the incuba- 
tion media of isolated cells were then obtained by further 
centrifugation as described previously (42), and samples 
of these were collected for analyses of hydrolase activi- 
ties. 
Cathepsin B1  (EC 3.4.22.1;  CB1)  activity  was deter- 
mined by  procedures described by  Szego et  al.  (59), 
using  carbobenzyloxy-alanyl-arginyl-arginyl-4-methoxy- 
~naphthylamide, a  synthetic substrate highly  specific 
for CB1  at a pH optimum of 6.2. Fluorescence of the 
reaction product, 4-methoxy-fl-naphthylamine, was de- 
termined at 420  nm, using an activation  beam of 292 
nm. A  series of concentrations of the amine was ana- 
lyzed concomitantly as  standard.  Activity of /3-glucu- 
ronidase  (/3-D-glucuronide  glucuronohydrolase;  EC 
3.2.1.31) was determined at pH 4.5 by the spectropho- 
tometric method of Fishman as modified by Musa et al. 
(31 ), using the substrate phenolphthalein-fl-D-monoglu- 
cosiduronic acid. 
Alkaline phosphatase (EC 3.1.3.1 ) activity was deter- 
mined in the presence of 5.1  mM magnesium acetate at 
pH  9.6  by  the fluorometric method of Campbell and 
Moss as described elsewhere (38).  Activity of succinate 
dehydrogenase (EC 1.3.99.1) was assessed at pH 7.4 as 
described by Pennington (36).  Lactate  dehydrogenase 
(EC 1.1.1.27) activity was determined at pH 8.8 by the 
method of Clark and Yochim (11). 
Preparation of Liposomes with or without 
Entrapped Leupeptin 
Liposomes composed of sphingomyelin, cholesterol, 
and  octadecylamine were  prepared by  the  method of 
Magee and et al. (27). The procedure for entrapment of 
leupeptin, a peptide aldehyde (acetyl-  and propionyl-L- 
leucyl-L-leucyl-L-arginal),  in  liposomes  was  described 
previously  (38).  Liposomes were stored in suspension at 
0~176  Before use  in  experiments with isolated cells, 
liposomes were washed by centrifugation at 60,000 g for 
30  rain  and  then  resuspended in  divalent  cation-free 
Ringer's solution. The final cholesterol contents of vehi- 
cle control- and leupeptin-liposomes, as determined by 
the method of Albers and Lowry (2), were not signifi- 
cantly  different and averaged 12.0  -+ 0.1  /xg of choles- 
terol per 5 ml of medium in 30 separate experiments. 
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Isolated Endometrial  Cells 
The degree of ceil-to-cell adhesion was determined by 
methods  similar  to  those  described  previously  (38). 
Isolated endometrial cells were filtered through 63-/xm 
nylon mesh. Thereafter, they (ca.  2  x  l0  s cells) were 
incubated in 5 ml of divalent cation-free Ringer's solu- 
tion with 0.1  mM EDTA and 1 mM sodium pyruvate. 
After 15,  30,  or 60 min with shaking (60 oscillations/ 
min) in the presence or absence of additives, cell suspen- 
sions  were  filtered  with  stirring  through  a  stop-flow 
apparatus. The apparatus was similar to that described 
elsewhere (40), except that a  63-/xm nylon mesh filter 
was fitted to the base (cf.  reference 38). Cells retained 
by the nylon mesh were then washed in the apparatus 
for two successive  1-min periods with 5-ml volumes of 
the  divalent  cation-free  Ringer's  solution.  Cells  not 
retained by the nylon mesh were sedimented by centrif- 
ugation  at  400  g  (5  min),  sonically  disrupted,  and 
analyzed for DNA content. Cells remaining on the nylon 
filter by virtue of aggregation were  also sonically dis- 
rupted, and samples were collected for determination of 
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FIGURE  1  Influence of proteinase inhibitors on Con A 
binding and Con  A-mediated hemadsorption to endo- 
metrial cells incubated with and without estrogens. En- 
dometrial  cells  were  exposed  for  30  min  at  22~  to 
various  concentrations of  proteinase  inhibitors before 
30-min incubation with 1  x  10-" M estrogen or vehicle. 
Lectin binding (lined bars) and lectin-mediated adsorp- 
tion of homologous erythrocytes  (shaded bars) to  the 
endometrial cells  were  determined as described previ- 
ously  (42).  All  values  are  presented  as  percent  of 
appropriate controls in three to five paired experiments. 
Baseline levels of Con A  binding and Con A-mediated 
hemadsorption to cells treated only with hormone vehi- 
cle, 0.02% ethanol, averaged 44.0 net fluorescence U/ 
mg cell protein (i.e., 0.25  mg protein/10  ~ endometrial 
cells) and  0.27  absorbance units  (at 418  nm)/mg cell 
protein, respectively.  A  value of 4.6  net  fluorescence 
units is equivalent to -0.10  /xg F. Con A  protein. The 
levels of lectin binding, as well as lectin-mediated hem- 
adsorption to cells incubated with proteinasc inhibitors 
alone  were  not  significantly  different  from  those  of 
vehicle controls (all at P  >  0.40; t test). 
DNA.  Viability of. cells (see below) decreased by only 
1% after 30-min incubation and filtration through the 
stop-flow apparatus. 
Determination of Cell Viability and 
Test Reagents 
Viability of  cells was  evaluated  by  a  dye-exclusion 
method. Endometrial cells were suspended in Ringer's 
solution with 0.05 %  nigrosin (NA 0683; Allied Chemi- 
cal Corp., Specialty Chemicals Div., Morristown, N. J .) 
for 5-10 rain at 37~  In the present investigation, 96 +- 
1%  of cells sampled in each experiment excluded the 
vital dye. Preparations in which cell viability was <92% 
were  discarded.  The viable cells in the several experi- 
ments  were  incubated  with  or  without  estradiol-17a 
(E2a), E2fl,  or estriol (E3; all from Schering Corp.), or 
with vehicle control  (0.02%  ethanol,  final concentra- 
tion). Proteinase inhibitors, including ovomucoid (type 
II-0),  L-5-amino- 1- (p-toluenesulfonyl)-amidopentyl- 
chloromethyl ketone (TLCK), iodoacetate, and soybean 
trypsin  inhibitor  (SBTI),  were  obtained  from  Sigma 
Chemical Co. (St. Louis, Mo.). 
Data Analysis 
Variability of the data is expressed as standard error 
of the  mean  with the  number of independent experi- 
ments in parentheses. The t  test was applied to assess 
the  differences between the  means of paired  or inde- 
pendent data, as appropriate. 
RESULTS 
Effect of Estrogens on Con A  Binding and 
Con A-Mediated Hemadsorption  To 
Endometrial  Cells 
Previous  studies  have  shown  that  endometrial 
cells  possess  specific  binding-sites for  F-Con  A. 
Cells bind the lectin maximally at a  concentration 
of  100  /xg  Con  A/ml  with  3-min  incubation  at 
22~  (42). Accordingly, Con A  binding was deter- 
mined under these conditions after incubation of 
cells with or without  estrogens  (E2fl,  E3)  for  30 
min. Although the absolute levels of lectin bound 
were slightly elevated by treatment of endometrial 
cells with estrogens at  1  ￿  10-" M, the hormone 
elicited no statistically significant increase in Con 
A  binding  as  compared  to  levels  determined  in 
paired cells exposed  only to vehicle control  (Fig. 
1). 
Con  A  also  mediates  the  adsorption  or  cross- 
linkage  of homologous  erythrocytes  to  epithelial 
cells labeled  with  the  multivalent lectin  (37,  38, 
42). Therefore, the association of rat erythrocytes 
with endometrial cells exposed to  100  /xg Con A/ 
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previously (42). These analyses provide a quanti- 
tative estimate of lectin-mediated cellular aggluti- 
nability, a  property known to be expressed more 
markedly in transformed cells than in their normal 
counterparts  (6,  9).  Accordingly, hemadsorption 
to isolated endometrial cells was determined im- 
mediately after  their  incubation  with  estrogens. 
Treatment with 1  ￿  10 -9 M  E2fl elicited marked 
increments in Con A-mediated hemadsorption by 
endometrial  cells  to  237%  of  that  by  paired 
controls (P  <  0.001;  Fig. 1).  A  more  moderate 
elevation  in  cellular agglutinability to  178%  of 
control levels (P <  0.01) was found also among 
cells exposed to 1 x  10 4  M E3 for 30 min. 
Influence of Proteinase Inhibitors on Con A 
Binding and Con A-Mediated 
Hemadsorption to Endometrial Cells Treated 
with E213 
The accentuated agglutinability of transformed 
cells has often been related to increased proteinase 
activity  associated  with  growth  stimulation  (cf. 
reference  33).  In  consideration  of  these  data, 
lectin-mediated  hemadsorption  by  endometrial 
cells treated with 1  ￿  10 -'~ M E~fl for 30 rain was 
determined after incubation of cells with or with- 
out proteinase inhibitors. 
Cells were treated for 30 min with 5  ￿  10 -4 M 
TLCK, a chloromethyl ketone selective for certain 
serine and thiol proteinases (7, 35), or 4.5  x  10 -7 
M  leupeptin, a  potent  antagonist of trypsin and 
cathepsin  B1  (59,  61).  Such treatments did not 
significantly alter the  level of Con  A  binding to 
cells as compared to paired vehicle controls (P > 
0.40;  Fig.  1).  However,  incubation of cells with 
either TLCK  or leupeptin before treatment with 
Fail evoked a  marked  decline in the  amount  of 
Con A-mediated hemadsorption to the endome- 
trial cells as compared with  the  response  in  the 
absence of the relevant inhibitor (P <  0.001 ; Fig. 
1). 
Ovomucoid  is  a  trypsin  inhibitor  with  weak 
antagonism toward cathepsin B1  (35, 59). Treat- 
ment of endometrial cells with this compound  at 
relatively high  concentrations  elicited partial re- 
ductions in Con A-mediated hemadsorption, but 
not  Con  A  binding, to  endometrial cells subse- 
quently exposed to E2/3, as compared with paired 
cells  treated  with  estrogen  in  the  absence  of 
ovomucoid (P <  0.05; Fig. 1). In contrast to the 
degree of effectiveness of leupeptin, TLCK, and 
ovomucoid, the serine proteinase inhibitor, SBTI, 
which  has  no  influence  on  the  activity of  thiol 
proteinases such  as cathepsin B1  (35),  failed to 
curtail the enhanced Con A-mediated hemadsorp- 
tion to endometrial cells attributable to E2/3 (Fig. 
1). Therefore, only those agents which are effec- 
tive  suppressors of certain  thiol  and  serine pro- 
teinases  (e.g.,  TLCK,  ovomucoid,  leupeptin) 
were  capable  of  counteracting  the  influence  of 
E2fl treatment on lectin-mediated hemadsorption 
to endometrial cells. 
Iodoacetate suppresses the activity of cathepsin 
Bl-like proteinases by reacting with the essential 
thioi group (7, 35,  59). Prior treatment of endo- 
metrial cells with  5  ￿  10 -~  M  iodoacetate  (30 
min)  elicited a  significant  reduction  in  Con  A- 
mediated hemadsorption, but not Con A  binding, 
to cells subsequently exposed to E2/3, as compared 
with paired cells treated with E2/3 in the absence 
of iodoacetate (P  <  0.001;  Fig.  1).  Thus,  these 
additional data strengthen the inference that sur- 
face alterations in response to E2fl treatment are 
associated with enhanced thiol proteinase activity 
of the cathepsin B 1-type. 
Influence of Estradiol on the Surface 
Distribution of Con A-Binding Sites and the 
Effect of Prior Treatment with Leupeptin 
Endometrial cells were incubated with or with- 
out  1  ￿  10-"  M  estrogen  for  5  rain  before 
exposure to 100/zg Con A/ml for 3  min at 22~ 
as described above. In light of the enhanced net 
rate  of  cellular  aggregation  after  exposure  to 
active estrogen  (see  below),  a  submaximal time 
period of 5 min of hormone treatment was used in 
the  present series. This expedient permitted ob- 
servations on the distribution of F. Con A  at the 
surfaces of predominantly individual cells. F. Con 
A  binding  to  cells was  evaluated  by  dark-field 
ultraviolet  fluorescence  microscopy.  When  500 
/zg unmodified Con A/mi was added with 100/zg 
F. Con A/ml, fluorescence at the cell surfaces was 
minimal,  thus  demonstrating  the  specificity  of 
F.Con  A  binding  (Fig.  2a).  In  the  absence  of 
excess unlabeled lectin, F. Con A  was distributed 
in apparently random patches over the surfaces of 
the majority of cells treated with hormone vehicle 
(Fig. 2b) or E~a (Fig. 2c).  In contrast, addition 
of E2/3 to cells evoked an apparent rearrangement 
of binding sites for Con  A  into polar clusters at 
the surfaces of -25%  of all isolated cells observed 
(Fig. 2d).  Such  "capping" was  not  observed in 
PIETI~S AND  SZEGO Estrogen  and Endometrial Cell Proteinase Activity  653 lq6uRe  2  Dark-field-ultraviolet fluorescence micrographs of F. Con A  binding for 3  min at  22~  to 
endometrial cells isolated from ovariectomized rats. Before exposure to F. Con A, cells were treated 5 
min in vitro with hormone vehicle (b), or with 1  x  10 4  MEaa (c), or 1  x  10 4  M Earl (d). Additional 
paired cells were incubated with 4.5  x  10  -~ M leupeptin for 30 min before exposure to hormone vehicle 
(e) or to 1 x  10 --~  M Earl (f). Binding of F. Con A at the cell surface could be blocked by the addition of 
a fivefold excess of unmodified Con A  (a). No significant alteration in the basal level of Con A binding to 
ceils was elicited by treatments described above (all at P  >  0.10; t test). Preparations were photographed 
on Kodak Tri-X Panatomic film (ASA 400). Approx. 50 cells in each treatment group were observed in 
each of three independent experiments. Bar, 5/zm. ￿  1,000. 
cells exposed only to hormone vehicle or E~a for 
up  to 30  min.  The  remaining  essentially 75%  of 
E2fl-treated cells exhibited a nonpolar distribution 
of  label  similar  to  that  shown  in  Fig.  2b.  In 
additional  experiments,  endometrial  cells  were 
exposed  to  4.5  ￿  10 -7  M  leupeptin  for  30  min 
before  5-min  incubation  with  hormone  vehicle 
(Fig. 2e) or Ed3  (Fig. 2f).  Such prior treatment 
with  proteinase  inhibitor  partially  blocked  the 
characteristic  redistribution  of  binding  sites  for 
F. Con  A  observed  in  cells  incubated  only  with 
Ezfl (Fig. 2 d). 
Analyses of [aH]E~fl Binding by Intact 
Endometrial Cells and Cytosol Fractions and 
the Effects of Proteinase Inhibitors 
As previously noted,  the specific accumulation 
of E213 by intact cells derived from endometrium 
is  a  saturable  process,  with  maximal  binding  of 
hormone  at  1  ￿  10 -'~ M  after 30-min incubation 
at 22~  (44). To determine the effects of protein- 
ase inhibitors on the extent of Ed3 binding in such 
cells,  specific  accumulation  of  1  ￿  10-"  M  Ez/3 
was measured  after 30-min prior incubation  with 
or without the various concentrations of leupeptin 
or  SBTI  indicated  in  Fig.  3.  Treatment  of  the 
endometrial  cells  with  50-250  /~g  SBTI/ml  did 
not influence the degree of specific F~/3  accumu- 
lation relative to that of cells treated with vehicle 
alone (all at P  >  0.80).  Exposure  of cells to 2  ￿ 
10 -s  M  leupeptin  likewise  elicited no  significant 
alteration  in  the  extent  of  estradiol  binding  as 
compared  to  controls  (P  >  0.90).  In  contrast, 
treatment with leupeptin at concentrations ranging 
from 9  x  10 -8 to 2  ￿  10 -6 M  promoted progres- 
sive reduction in F-a/3 uptake  to -60%  of control 
levels at the latter concentration.  Testing of E2/3 
binding  by  intact  cells in  the  presence  of higher 
levels of leupeptin was not possible because expo- 
sure of cells to  10 -5 to  10  -4 M  concentrations  of 
leupeptin  was  found  to  reduce  the  percent  of 
viable cells below acceptable  levels (cf. reference 
61). 
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Effects of proteinase inhibitors on  [aH]F~fl 
binding  to  intact  endometrial  ceils and  to  high-speed 
supernatant  fractions  obtained  after  cell  homogeniza- 
tion. Intact cells were incubated in Ringer's solution with 
(closed  circles)  or  without  leupeptin  or  SBTI  (open 
circles) at the concentrations indicated for 30 min before 
exposure to 1  ￿  10 4  M  [3H]E~fl for 30 min at 22~ 
Cytosol  fractions  in  Tris-buffered  solution  were  incu- 
bated with (triangles) or without leupeptin for 1 h at 4~ 
before incubation  with hormone  for 2  h  at 4~  Only 
specific  binding  (defined  as  the  difference  in  bound 
steroid between paired tubes, one of which contained a 
200-fold excess of unlabeled E2fl throughout the experi- 
ment)  is  shown.  All  values  are  given  as  percent  of 
specific  E~fl binding in  paired  cells incubated  without 
proteinase inhibitors (i.e., 24,597  --- 824 dpm  [aH]E~/~ 
bound/mg cell protein) or paired supernatant  fractions 
not  exposed  to  leupeptin  (i.e.,  31,730  -+  1050  dpm 
[aI-l]E2fl bound/mg  cytosol  protein)  in  two  to  three 
independent experiments.  Means of duplicate determi- 
nations are shown without the SEM given in the cases of 
triplicates. 
The  influence  of  leupeptin  on  binding  of 
[3H]E2/3  by  endometrial  cells  at  22~  was  ana- 
lyzed further  in  equilibrium-binding experiments 
(Fig. 4). After a  30-min incubation with or with- 
out 4.5  ￿  10 -7 M  leupeptin,  cells  (2  ￿  107/ml) 
were  exposed  to  a  series  of  [ZH]E2fl concentra- 
tions ranging from 1  x 10 -l~ to 2.5  ￿  10 -'~ M  for 
30  min.  The  specific  binding  of  E2/3  by  cells 
treated  with  or  without  the  peptide  aldehyde  is 
presented in Fig. 4. To obtain both the concentra- 
tion  of  specific  binding  sites  for  E2/3  and  the 
equilibrium  constant  for  the  binding  reaction  in 
each group,  data in Fig. 4  were analyzed further 
(see  Fig.  4,  inset)  by  the  notation  of  Scatchard 
(49).  Mathematical resolution of the binding data 
by the method of least squares yields an apparent 
molar dissociation constant for the binding process 
of 1.9  x  10 -~ among cells not exposed to leupep- 
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FIGURE 4  Influence  of  4.5  x  10 -r  M  leupeptin  on 
binding of [aI-I]E~/3 by intact endometrial cells.  After a 
30-min incubation with (closed circles) or without (open 
circles)  leupeptin,  approx.  2  x  10  r  endometrial  cells 
(i.e., 5 mg cell protein) per ml Ringer's solution were 
exposed for 30 rain to a series of [aI-I]E2/~  concentrations 
ranging from 1 x  10 -1~ to 2.5  x  10--9 M as indicated on 
the abscissa.  Only specific binding of [aH]E~fl (see Fig. 
3) is shown. Each point represents the mean of values 
obtained in two independent experiments. A  Scatchard 
(49) plot of estradiol binding in cells with (closed circles) 
or without (open circles) prior exposure to leupeptin is 
shown  as  an  inset.  Calculation of these  latter data  is 
similar to that described by others (1, 62). The mass of 
bound estradiol is obtained from the specific radioactiv- 
ity of the hormone associated with the cells. The concen- 
tration  of  E~/3 so  bound  is  obtained  by  estimating  a 
volume of 1 x  10 -s liter per 2  x  l0  T endometrial cells 
(i.e.,  2  ￿  10  0  packed  cells/ml).  The  free  estradiol 
(unbound)  at  the  end  of the  incubation  is  calculated 
from the  difference between the  total  amount  of E2fl 
added initially to the incubation medium and the amount 
of bound hormone. 
tin, as compared to 2.0  ￿  10 -8 in cells pretreated 
with the proteinase inhibitor. The total number of 
Ed9  binding  sites  per  cell  at  saturation  corre- 
sponds to 21,110 in control cells and to 20,840 in 
leupeptin-treated  cells  (see  Fig.  4,  inset).  Thus, 
prior  exposure  of endometrial  cells  to  leupeptin 
elicits  a  reduction  in  the  affinity  of  hormone 
binding by intact cells without substantially affect- 
ing the apparent  number of binding sites per cell. 
Specific  binding  of  1  x  10-"  M  [aH]E2fl  to 
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dometrial cells was determined after 2-h incuba- 
tion at 4~  Treatment  of the supernatant  frac- 
tions with 2  x  10 -8 to 2  x  10  -~ M  leupeptin at 
4~  for  1  h  before  incubation  with  hormone 
elicited no significant alteration in Ed3 binding as 
compared to control levels (P >  0.70; Fig. 3). In 
additional studies, specific binding of 2  ￿  10  -x~ or 
6  x  10  -1~ M  [all]E2/3 to macromolecular compo- 
nents of cytosol was likewise uninfluenced by prior 
incubation  with  4.5  ￿  10  -7  M  leupeptin  (not 
shown).  Thus,  only  binding  of  Ez/3  by  intact 
endometrial cells is reduced by treatment with the 
peptide aldehyde. 
Activities of  Hydrolytic Enzymes Released 
into the Particle-Free  Medium from 
Endometrial Cells and the Effect of 
Estrogen Treatment 
Considerable biochemical and morphologic evi- 
dence  demonstrates  that  estrogens  elicit  rapid 
reduction  in  the  structural  latency  of lysosomal 
components in specific target cells (cf. reference 
57). Determinations of the extracellular release of 
a  variety of hydrolases were undertaken  among 
endometrial cells treated for 30 min with several 
estrogenic congeners. The results are presented in 
Table I. Ez/3,  but not E2a, elicited a  statistically 
significant increase in the extracellular release of 
the acid hydrolases cathepsin B1  and fl-glucuron- 
idase from cells incubated with steroid at a  con- 
centration  of  1  ￿  10 -"  M,  as  compared  with 
paired cells exposed to  control vehicle during a 
30-min incubation period. A  moderate elevation 
of  extracellular cathepsin  activity  was  also  de- 
tected  among  endometrial  cells  treated  with  1 
￿  10 -'~ M  of the less active estrogen, E.~, relative 
to that at the external surfaces of paired controls. 
In  contrast,  treatment  with  estrogens  did  not 
significantly enhance the extracellular activities of 
several nonlysosomal enzymes including alkaline 
phosphatase (Table I), nor of succinate dehydro- 
genase  and  lactate  dehydrogenase  (not  shown). 
Activities of the latter two dehydrogenases were 
not detectable in extracellular media from either 
control or estrogen-treated cells. Thus,  endome- 
trial cells treated with physiologically  potent estro- 
gens  appear to  release selectively lysosomal en- 
zymes  at  the  external  cell  surface.  The  more 
sensitive  and  consistent  indicator  of  treatment 
with  estrogens  by  this  criterion  was  the  thiol 
proteinase, cathepsin Bt. 
Inhibition by Liposome-Entrapped 
Leupeptin of Estrogen-Induced 
Incorporation of  [aH]Thymidine into 
Macromolecular Form and of  the 
Proliferative Response to Hormone 
Mounting  evidence  indicates that  an  endoge- 
nous proteinase may contribute to the estrogenic 
regulation of cell proliferation in  uterine  tissues 
(24, 47,  59). The data presented above likewise 
suggest  that  a  cellular  proteinase  sensitive  to 
marked inhibition by leupeptin is involved in the 
mediation of specific surface alterations induced 
by  Ezfl  treatment.  These  data  prompted  us  to 
analyze the mitogenic actions of estradiol in pri- 
mary cultures of endometrial cells, with and with- 
out modification of leupeptin-sensitive proteinase 
activity. 
Endometrial cells cultured in CDM showed no 
significant growth response to treatment with 1 ￿ 
10 -9 M  E2c~. Thus,  [aH]thymidine incorporation, 
determined after 20-h (P >  0.40), and cell prolif- 
eration after 24-h (P >  0.90; data not shown) or 
48-h  (P  >  0.20) exposure to this relatively inert 
estrogen were essentially unchanged from control 
levels (Fig. 5a). In contrast, after treatment with 
1  x  10  -.~  M  E2/3, [SH]thymidine incorporation 
was enhanced  to  241  +-  12%  of controls (P  < 
0.001 ), while gross cell numbers after 24 and 48 h 
increased  to  138  •  2%  (P  <  0.01;  data  not 
shown) and 208  •  5% (P <  0.001), respectively, 
of control levels. 
The effect of leupeptin on E2fl-induced altera- 
tions in cell growth was first tested by an initial 
incubation of cell cultures for 30  min  with 7  x 
10  -8 M  of the proteinase inhibitor. The superna- 
rant medium was then removed by centrifugation 
at 400  g  for  5  rain.  The  sedimented ceils were 
washed  once  by  centrifugation,  resuspended  in 
culture medium,  and  then  divided into two por- 
tions. One portion was analyzed for total cellular 
cathepsin B1  and  additional hydrolase activities 
(see  Table  II),  while  the  other  was  incubated 
further in the presence of F~/3 or control vehicle. 
Such treatment with leupeptin reduced total cel- 
lular cathepsin B 1 activity to 77  --- 5 %  of control 
levels,  without  demonstrable  effect  on  ~glucu- 
ronidase,  alkaline phosphatase,  or succinate  de- 
hydrogenase activities (Table II). 
In the second portion of the leupeptin-treated 
cells, subsequent incubation with E2/3 resulted in 
an increase in [3H]thymidine incorporation to 215 
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Effect of Estrogen Treatment for 30 rain on Activities of Hydrolytic Enzymes in the Particle-Free  Media from 
Suspensions o  f Endometrial Cells 
Extracellular enzyme activity 
Group  Cathepsin B 1  ~-Glucuronidase  Alkaline phosphatase 
pmol  /min/mg  cell protein * 
Control (0.02% ethanol)  43 -+ 3 (5)  2,227  -+ 30 (5)  10 --+ 1 (5) 
E~a (1  x  10 -~ M)  45 -  1 (3)  2,272  -+ 42 (3)  11 -+ 2 (3) 
E~fl(1 x  10~M)  88-+ 1 (5~  2,606- 48 (5)w  11 --+ 1 (5) 
Ea (1  ￿  10 a M)  70 -+ 2 (3)[ [  2,450 -  102 (3)  10 -+ 2 (3) 
* After 30-rain  incubation at 22~  with or without estrogens, enzyme activities detected in particle-free supematant 
fractions from cell suspensions  were <0.5% of total available cell hydrolase activities; no significant change in total 
enzyme contents was found after 30-rain E,  fl treatment (P >  0.80 vs. controls). 
:~ Value significantly  different from control at P  <  0.001. 
w Value significantly  different from control at P  <  0.05. 
1I Value significantly  different from control at P  <  0.01. 
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lqou~  5  The influence of free or liposome-entrapped leupeptin on estrogen-enhanced incorporation of 
[aH]thymidine  into  acid-precipitable  form  and  on  proliferation  of  endometrial  cells.  Values  of 
[aH]thymidine  incorporation after 20 h (clear bars) and cell numbers after 2 d of incubation (shaded bars) 
were obtained in three  to four independent experiments in the presence and  absence  of 1  ￿  10 4  M 
estrogen, as indicated. See text for details. 
•  18%  of appropriate  controls  not  exposed  to 
hormone  (P  <  0.00i;  Fig.  5b).  An  increase  in 
cell numbers  limited  to  150%  of controls  (P  < 
0.001)  was also  found  in  cultures  that  had  been 
treated with free leupeptin and then incubated  in 
the  presence  of  E2/~  for  2  d  (Fig.  5b).  These 
combined  data  reflect  a  moderate  reduction  in 
cellular  sensitivity  to  E2/3  resulting  from  prior 
treatment  with  leupeptin  as  compared  to  these 
criteria  of hormonal  response  in  the  absence  of 
the proteinase inhibitor (Fig. 5 a). 
To achieve more efficient delivery of leupeptin 
to  the  cell interior,  the  proteinase  inhibitor  was 
entrapped  in  cationic  liposomes.  Cell  cultures 
were incubated with liposomes containing leupep- 
tin  at  a  final  concentration  of 7  ￿  10 -8  M.  In 
preliminary  experiments,  prolonged  exposure  of 
cells to liposomes as such was found to reduce the 
percent  of  viable  cells  below  acceptable  levels. 
Therefore,  the incubation  medium  was removed 
after  30  min  and  replaced  with  fresh  medium 
before  proceeding  to  assessment  of  estrogen-in- 
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Effects of Brief Incubation  of Endometrial  Cells with Free or Liposome-Entrapped Leupeptin  on Total Activities 
of Various Hydrolytic  Enzymes 
Cellular enzyme  activity 
Suecinate  dehy- 
Treatment  Cathepsin  B  1  /3431ucuronidase  Alkaline phosphatase  drogenase 
nmol/minlmg cell protein* 
Control vehicle  14.2  •  2.0 (3)  3,040 •  120 (3)  47 +-- 4  (3)  7.0 (2) 
Leupeptin (7 ￿  10  -8 M)  10.9 --- 0.7 (3):~  3,201  --- 112 (3)  50 -  3 (3)  7.2 (2) 
Controlqiposomes  13.1  -+ 1.5 (3)  2,800 -+ 140 (3)  43 •  3 (3)  6.8 (2) 
Leupeptin-liposomes  4.6 •  0.8 (3)w  2,982  •  121  (3)  45 •  4 (3)  7.0 (2) 
* Endometrial cells were treated for 30 min as indicated in the table and then sedimented and washed once with 
centrifugation at 400 g  for 10 rain. Sedimented cells were sonicated and then solubilized in 0.1% (vol/vol) Triton 
X-100 at 4~  (2 h). Portions of the sediment thus solubilized were analyzed for protein and enzyme activities as 
described in the text. 
~t Value significantly different from paired control at P  <  0.05. 
w Value significantly different from paired control at P  <  0.001. 
duced  proliferative responses.  Such  brief  treat- 
ment reduced the total cellular cathepsin B 1 activ- 
ity to 35  +  3% of that in control cells exposed to 
liposomes without  leupeptin  (Table  II).  Under 
these  conditions,  the  marked  stimulation  of 
[ZH]thymidine incorporation normally elicited by 
E2/3  was  essentially abolished,  amounting  to  a 
mere  110  -  19%  of that among cells incubated 
with control-liposomes (P  <  0.001;  Fig.  5c).  In 
addition, Ez/?,-induced cell growth, as determined 
from counts of cell numbers after 2 d, remained at 
a  level  not  significantly different  from  that  of 
appropriate controls not exposed to hormone  (P 
>  0.40). In contrast, cells incubated with control- 
liposomes before Ezfl treatment showed the antic- 
ipated increase in both  [ZH]thymidine incorpora- 
tion and cell proliferation (both at P  <  0.001  vs. 
appropriate control; Fig.  5c).  Throughout  these 
experiments,  samples  of liposome-exposed cells 
retained the capacity to exclude nigrosin, and the 
numbers  of  viable  cells  as  determined  by  this 
criterion exceeded 92 %  in each experiment. 
Effects of Estrogens on Aggregation of 
Endometrial Cells and the Influence of Prior 
Treatment With Leupeptin 
Recent studies demonstrate that chemical trans- 
formation of epithelial cells from urinary bladder 
is associated with an increase in the rate of inter- 
cellular adhesion (38). The net rate of aggregation 
of endometrial cells during 15-, 30-, and 60-min 
incubation was analyzed under similar conditions, 
as specified in Table III. The net rate as measured 
TABLE III 
Effect of Estrogens  on the Aggregation  of Endome- 
trial Cells and the Influence  of Prior  Treatment  with 
Leupcptin 
~g DNA cells  retained/ 
Group  t~g DNA input  cells* 
Control (0.02% ethanol) 
E2a(1  x10 4M) 
~t~ (2  ￿  10 4  M) 
Leupeptin (4.5  x  10 -7 M) and 
vehicle control 
Leupeptin and Fe/3 
o.00 •  o.00 (4) 
o.oo (2) 
0.34 -  0.02 (4):~ 
0.00 (2) 
0.03  •  0.01  (3) 
* Endometrial cells were suspended in divalent cation- 
free Ringer's with 0.1  mM EDTA and 1 mM sodium 
pyruvate,  and filtered over 63-/~m  nylon mesh.  Fil- 
tered cells were  then incubated for  30  min  at  22~ 
with or without estrogens as indicated in the table. In 
experiments with leupeptin, ceils were incubated with 
the peptide  aldehyde for 30  rain  before the 30-min 
treatment with FeB or hormone vehicle. At the end of 
the treatment period, cells were filtered again over 63- 
/~m  nylon and washed twice with 2  vol of medium. 
Cells retained by the filter and those passed through 
the  63-~m  mesh  were  collected  and  analyzed  for 
DNA. The extent of intercellular adhesion was then 
expressed as the ratio of txg DNA of cells retained by 
the filter to/~g DNA of all cells in suspension at the 
start of the procedure (i.e., input ceils). 
~: Value significantly different from that of paired control 
at P  <  0.001. 
here  is  a  function  of both  the  rate  of formation 
and the rate  of dissociation of intercellular  adhe- 
sions. 
Essentially no aggregation  of endometrial cells 
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the presence  of hormone  vehicle or 1  x  10 -,q M 
E2a.  In contrast,  exposure of cells to 1  x  10 -'~ M 
E2fl elicited aggregation of 16  +-- 2%  (n  =  3) of 
input  cells by  15  min,  34  -+  2%  by 30  min  (see 
Table  III),  and  35%  (n  =  2) by 60  min.  Thus, 
indications  of  apparently  maximal  intercellular 
adhesion were evident by 30 min incubation time, 
and these values are shown in Table III. 
Prior exposure of cells to 4.5  ￿  10 -7 M  leupep- 
tin for 30 min did not elicit aggregation of endo- 
metrial cells during  a  subsequent  30-min  incuba- 
tion with hormone vehicle (Table III). However, 
cells exposed  to  hormone  for 30  min after  prior 
treatment  for  30  min  with  leupeptin  exhibited 
only  a  minimal  level  of  intercellular  adhesion 
which  was  significantly  less  than  that  of  cells 
incubated with E2fl in the absence of the protein- 
ase inhibitor (P <  0.001 ; Table III). 
Fractionation of Endometrial Cells with 
Differential Responsiveness to Ezfl 
The  growth,  lectin-mediated  hemadsorption, 
and  proteinase-secretory  properties  of cells frac- 
tionated  by  virtue  of their  differential  adhesive- 
ness were analyzed in further experiments.  After 
treatment  of cells with  1  ￿  10 4  M  estrogen  or 
vehicle control for 30 min, adherent cells retained 
in  the  stop-flow  apparatus  were  collected  and 
maintained  apart  from  nonadherent  cells  that 
were not excluded by the 63-/xm filter. 
After isolation of these fundamentally dissimilar 
fractions  of  the  original  mixed  cell  population, 
they were incubated  for 30  min and  analyses for 
cathepsin  B1  activity  in  the  extracellular  media 
were  conducted  (Table  IV).  Proteinase  activity 
released by adherent cells was elevated to 250  -+ 
25%  of that  by nonadherent  cells that  had  been 
exposed to E2fl while still in suspension with their 
adherent counterparts  (P <  0.05).  Moreover, the 
adherent  cells  exhibited  levels  of  cathepsin  B1 
secretion more than 3.3-fold greater than  that  of 
cells exposed only to control vehicle. 
The  association  of erythrocytes  with  adherent 
and  nonadherent  endometrial  cells  exposed  to 
Con A  was also determined immediately after cell 
fractionation.  As shown in Table IV, adherent as 
well as nonadherent cells, both of which had been 
exposed  to  E2fl,  exhibited  increases  in  Con  A- 
mediated  hemadsorption  as  compared  to  those 
levels in vehicle-control cells. However, the extent 
of lectin-mediated hemadsorption to the adherent 
group  of hormone-treated  cells exceeded that  of 
nonadherent  cells exposed to Ezfl by three times 
(P <  0.01). This parallel between the results from 
two  completely  independent  probes  for  Ez/3-in- 
duced changes in membrane properties is striking. 
No  significant  difference  in  Con  A  binding  to 
endometrial  cells  was  elicited by  treatment  with 
E2fl as compared  to  the binding levels measured 
in cells treated only with hormone vehicle (both at 
P  >  0.50; data not shown). 
TABLE IV 
Extracellular Release of Cathepsin B1 Activity and Lectin-Mediated Hemadsorption in Adherent and 
Nonadherent Endometrial Cells* 
Group  Prior treatment 
Extracellular  release  of ca- 
thepsin  B1 activity in 30 rain 
(% total cellular activity) 
Con A-mediated hemadsorption 
(absorbance,  418 nm/mg endo- 
metrial cell protein) 
Nonadherent cells  Control (0.02% ethanol) 
E2fl(1  x  10 4M) 
0.3 -+ 0.0  (3)  0.24 +-- 0.02 (3) 
0.4 -+ 0.1  (3)  0.31  -+ 0.02 (3)(: 
Adherent cells  E2/3 (1  x  10 -9 M)  1.0 ~  0.1w (3)  0.93 +- 0.08 (3)(: 
* Endometrial cells were incubated with 1 ￿  10 -a M E2fl or hormone vehicle for 30 min and then filtered over 63- 
p.m nylon mesh as described in the text. Cells retained by the filter (adherent cells) and those passed through the 
mesh (nonadherent  cells) were collected, sedimented by centrifugation  at 400 g  (5  min),  and  resuspended  in 
complete Ringer's solution. As in experiments shown in Table III, no adherent cells resulted from exposure to 
hormone vehicle. For studies of extracellular cathepsin B1 release, cells (approx. 3  ￿  10~/ml) were incubated for 
30 min at  22~  and  then prepared  for enzyme analyses as described  in  the text. The total cellular activity  of 
cathepsin per mg cell protein was  not significantly  different among the several treatment groups. For studies  of 
Con A-mediated hemadsorption to endometrial cells,  approx.  2  ￿  10  ~ cells per 5 ml of Ringer's solution were 
incubated for 3  min with 100  /xg Con A/ml and then prepared for assessment  of hemadsorption to the lectin- 
labeled cells as described in the text. 
(: Values significantly  different from that of paired control at P  <  0.01. 
w Value significantly  different from that of paired control at P  <  0.05. 
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cultured in CDM  for  22  h  after isolation by the 
adhesion  procedure  was  also  determined  (Table 
V).  Thymidine  incorporation  by  adherent  cells 
treated  with  E2fl  was  528  -  26%  of  that  by 
nonadherent  cells  exposed  to  hormone  (P  < 
0.001),  and 569  -+  28%  of that  by cells in the 
vehicle-control group  (Table V).  These  marked 
increments in nucleotide incorporation were con- 
sistent  with  independent  measurements  of  in- 
creased  DNA  contents  in  paired  cell  cultures 
incubated under the  same conditions for 26  and 
50  h  (Table V).  Thus, isolation of a  fraction of 
endometrial cells by selection for an Ezfl-induced 
membrane  alteration  also  yields  a  cell  fraction 
highly  sensitive  to  the  mitogenic  effects  of  the 
hormone. 
DISCUSSION 
The  present  studies provide  evidence  that  early 
alterations  induced  by  E2fl  at  the  surfaces  of 
endometrial  cells,  as  well  as  enhanced  growth 
evoked  by the  hormone  in primary culture,  are 
both  associated with increased  availability of an 
endogenous leupeptin-sensitive proteinase. Treat- 
ment of cells with F-eft evokes a  sharp rise in the 
access of cathepsin Bl-like activity to the external 
cell surfaces.  In contrast, extracellular activity of 
the proteinase is substantially less in cells exposed 
to  E3,  a  weak  mitogen  (cf.  reference  4),  and 
unchanged from that  of controls in cells treated 
with the relatively inert congener, E2a. Additional 
investigations also  show  a  marked  enhancement 
of cathepsin B1  activity in the extracellular envi- 
ronment of isolated cells from endometrium and 
urinary bladder treated with either diethylstilbes- 
trol  or  a  carcinogenic  nitrosamine,  respectively 
(38, 43). Moreover, other reports demonstrate a 
striking immunohistochemical localization of ca- 
thepsin  B1  at  the  surfaces  of  transformed  and 
tumor cells (55) and marked elevation of cathep- 
sin  Bl-like  activity  in the  sera  of  patients  with 
cancer (46). 
Recent data indicate that reorganization of the 
cell  surface  may  be  an  obligatory  step  in  the 
normal progression of cells to mitosis (9, 10, 14, 
33, 42,  53).  In this context, cathepsin-mediated 
alterations  in  the  enzymatic  activity  or  in  the 
integrity of membrane-associated proteins by lim- 
ited proteolysis may contribute to such changes in 
the composition or distribution of membrane com- 
ponents (cf. reference 51). The present data pro- 
vide evidence that estrogen-induced secretion of a 
cathepsin  B l-like  proteinase  may  promote  the 
expression  of cell surface  modifications well be- 
fore initiation of DNA synthesis due to hormone. 
Treatment of cells with Ed3, but not E2a, for only 
5 min elicited in 425 %  of exposed cells a redistri- 
bution into polar clusters of Con A-binding sites 
normally disposed in random patches at the exter- 
nal cell surface. Due to the submaximal period of 
hormone  exposure  in the  latter experiment,  the 
reported percentage is probably a  minimum esti- 
mate of the actual proportion of responsive cells. 
However,  the  results establish that  E2~induced 
redistribution of lectin-binding sites occurs at tar- 
get  cell  surfaces  either  before  or  concomitantly 
with  a  hormone-stimulated  increase  in  Con  A- 
TABLE V 
Incorporation of [ZH]Thymidine and Growth in Adherent and Nonadherent Endometrial Cells* 
dpm [3H]th~.~nidine  in-  ~g DNA after 26 h/initial  p,g DNA after 50 h/initial 
Group  Prior treatment  corp.//xg DNAI22  h  tzg DNA  ~,g DNA 
Nonadherent cells  Control (0.02% ethanol)  118 -+ 4  (4)  1.02 -+ 0.01 (3)  1.06 m 0.05 (3) 
Ezfl (1  x  10 -9 M)  127 -+ 5  (4)  1.06 -+ 0.04 (3)  1.09 -+ 0.08 (3) 
Adherent Cells  Ed3 (1 x  10  -,~ M)  671  +- 33 (4~  1.96 _  0.06 (3)~:  3.86 -+ 0.07 (3)r 
* Endometrial cells were filtered over 63-tzm nylon mesh after treatment with or without 1 x  10 -9 M E~fl for 30 min 
at 22~  As indicated in Table III, ~34% of cells exposed to Ee/3 were retained by the filter (adherent cells), while 
the remainder were  not (nonadherent group); vehicle-control  cells were  not retained by the filter.  Groups of 
adherent and nonadherent cells were sedimented by centrifugation at 400 g for 5 rain. Cells were then suspended 
in CDM and allowed to attach to culture dishes at 37~  in a humidified atmosphere of 5% CO2 in air. After 2 h, 
the medium was exchanged for 5 ml of fresh CDM. Determinations of DNA synthesis  among the several  cell 
fractions were then begun with approx. 5 x  10  ~ cells/dish in each experiment. Incorporation of [3H]thymidine into 
acid-precipitable  form was analzyed 22 h after fraetionation of cells by the adhesion procedure. In independent 
experiments, levels of total cell DNA were determined after 26 or 50 h. 
:~ Value significantly different from that of paired control at P  <  0.001. 
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minimal increases in the levels of lectin binding by 
E2/3-treated as compared with control cells in the 
present and in previous studies (42, 43) are inad- 
equate to explain  the marked differences in Con 
A-mediated hemadsorption  to endometrial  cells. 
Other investigators have reported a clustering of 
lectin-binding sites  and  an increase  in lectin-me- 
diated agglutination in transformed cells of various 
types  and  have  considered  both  events  to  be  a 
consequence  of  increased  lateral  movement  of 
lectin-binding  components  in  the  plane  of  the 
membrane  (cf.  references 9  and 33). The contri- 
bution  to lectin  reactivity of the latter and addi- 
tional factors such  as E~fl-induced  alterations  in 
microvillous formations at  the  surfaces of endo- 
metrial cells  (cf. references 5 and 33) remains to 
be evaluated. 
Additional evidence of plasma membrane alter- 
ations  early  after  E2fl  treatment  was  found  in 
studies of intercellular adhesion. The active estro- 
gen, but not E2a, elicited marked aggregation of 
-34%  of endometrial  cells.  Such  E~fl-induced 
changes were sensitive to blockade by prior treat- 
ment  with  leupeptin.  Moreover,  selection  of 
highly adherent cells by the adhesion method after 
estrogen treatment yielded a cell fraction that was 
profoundly  effective  without  further  challenge 
with the hormone in the release of cathepsin B1, 
Con  A-mediated  hemagglutination,  and  DNA 
synthesis as compared to their nonadherent coun- 
terparts. These results are consistent with previous 
work  which  indicated  that  -40%  of  similarly 
isolated  endometrial  cells  bear  surface-binding 
sites specific for interaction with immobilized es- 
tradiol  (44).  In  independent  studies  in  which 
endometrial cells were isolated from uteri of ovari- 
ectomized rodents by comparable procedures  (1, 
54),  the  authors  estimated  that  75-85%  of the 
cell  population  was  composed  of  luminal  and 
glandular epithelial cells, with the remainder, cells 
of the connective tissue stroma. Autoradiographic 
studies  of  [3H]thymidine  incorporation  in  thin 
uterine  sections  show  that  70-80%  of  luminal 
epithelial  cells,  20-30%  of glandular  epithelial 
cells,  and essentially no stromal cells  are labeled 
with the nucleotide after 15-h treatment with E2fl 
in vivo (28). Thus, the present results obtained by 
in  vitro  treatment  with  hormone  are  consonant 
with  the  latter  in  vivo  observation  that  the  re- 
sponse of endometrial cells to E2fl is not uniform 
among the several cell  types. Additional work is 
necessary to establish the nature and properties of 
such  preferentially  responsive cells.  The  present 
methods  of  cell  fractionation  by  surface-mem- 
brane behavior should aid in such studies on the 
disposition  of functionally  divergent  cells  in  the 
uterus. 
Lysosomes  of responsive  cells  are  known  to 
concentrate a  wide variety of chemical mitogens 
(cf.  reference  3)  and  possess  binding  sites  with 
specificity  for  E2fl  (16,  21,  57).  Further,  the 
redistribution of limited concentrations of lysoso- 
mal hydrolases (59) and antigens from this organ- 
elle (58) to the nuclear compartment and external 
surfaces of target cells after E2fl exposure has also 
been  reported.  These  cellular  responses  to  hor- 
mone may correspond to the coupled processes of 
endocytosis and  lysosomal fusion  (cf.  references 
12  and 57),  processes which are being exploited 
as a means of introduction of antitumor drugs into 
the cell interior  (13).  Similarly,  the present  data 
show  that  treatment  of  endometrial  cells  with 
leupeptin-loaded liposomes evokes a marked sup- 
pression of the anticipated growth response after 
E2~  exposure.  Such  observations  lend  further 
support to the concept that a  leupeptin-sensitive 
proteinase  may promote enhanced genic expres- 
sion induced by estrogens (24, 57, 59). Independ- 
ent studies show that subcutaneous administration 
of milligram amounts of leupeptin to normal cyclic 
rats elicits  a  dramatic decrease  in uterine  weight 
and  DNA  content,  and  in  fertility  rates  (24). 
Moreover, leupeptin also inhibits the stimulation 
of  [aH]thymidine  incorporation  by phytohemag- 
glutinin in lymphocytes (48), restricts the growth 
of normal and polyoma-transformed kidney cells 
in culture  (29),  and diminishes tumorigenesis in- 
duced by a variety of chemicals (38, 61). 
The inhibition of endometrial cell responses to 
E2fl by leupeptin may also be attributable, in part, 
to reduction of hormone  accumulation by intact 
cells  after exposure to the proteinase inhibitor as 
shown  in  the  present  experiments.  Independent 
studies have demonstrated that various sulfhydryl- 
group  blocking  reagents,  including  iodoacetate 
and iodoacetamide, potential inhibitors of cathep- 
sin B1 activity (7, 35), restrict the entry of estro- 
gen into uterine cells while exerting markedly less 
inhibition of the binding of the steroid by cytosol 
receptor (30, 60).  Iodoacetamide was also found 
to suppress the nuclear accumulation of estradiol- 
receptor  complexes  (30).  It  is  conceivable  that 
both leupeptin  and sulfhydryl-group blockers are 
acting on a proposed Ca2+-activated enzyme (47, 
52,  59) that may be necessary for the estrogen- 
PmTRAS AND SZEC;O Estrogen and Endometrial Cell Proteinase Activity  661 triggered transformation (23) of the native estra- 
diol-receptor complex into a modified (52) mole- 
cule capable of binding to nuclear acceptor sites. 
A  crude preparation of an intracellular Ca2+-de  - 
pendent proteinase that exhibits maximal activity 
at  pH  8.5  and  that  possesses  high  affinity for 
native estradiol-receptor from calf uterus has re- 
cently been  described (47).  Limited amounts  of 
CaZ§  lysosomal proteinase, exhibiting a 
pH optimum of 6.2  with synthetic substrate and 
possessing additional cathepsin B l-like properties, 
are transferred rapidly into the nuclear compart- 
ment  of  target  cells  after  E2/3 treatment  (59). 
These  considerations,  as  well  as  additional evi- 
dence  of  the  occurrence  of  neutral  proteinase 
activities with (24, 50) or without (34) a require- 
ment for Ca  z+ in estrogen-responsive tissues, re- 
quire further investigation. 
There are additional implications of the present 
data in light of recent evidence that binding sites 
with high affinity and specificity for E2/3 occur at 
the  plasma membranes  of responsive  cells  (38, 
44) and may mediate the uptake of hormone (30, 
57).  Previous  reports  indicated  that  >70%  of 
native estradiol-receptor components possess high 
affinity for target cell membranes and are seques- 
tered in  discrete extranuclear compartments be- 
fore interaction with E2/3 (22). Thus, it is conceiv- 
able  that  enhanced  availability of  a  leupeptin- 
sensitive proteinase at the  surface membrane  of 
target  cells  after  E2/3 treatment  may  promote 
cleavage  of  an  estrogen-binding  fragment  with 
high nuclear affinity from  a  membrane-localized 
binding component. The control of zymogen acti- 
vation  by  limited proteolysis (cf.  reference  32) 
offers  ample  precedent  for  this  suggestion. 
Clearly, the concept of a proteinase-sensitive pro- 
receptor  component  as  presently postulated  re- 
quires intensive analysis in future  investigations. 
Such  studies  may,  in  turn,  advance  our  under- 
standing of the relation of membrane  alterations 
elicited by estrogen to processes leading to mito- 
genesis in responsive cells. 
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